Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials

M. Thind*, W. Zareba, D. Atar, H.J.G.M. Crijns, J. Zhu, H.N. Pak, J. Reiffel, U. Ludwigs, M. Wieloch, J. Stewart, P. Kowey

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)101-109
Number of pages9
JournalClinical Cardiology
Volume45
Issue number1
Early online date1 Jan 2022
DOIs
Publication statusPublished - Jan 2022

Keywords

  • antiarrhythmic drugs
  • atrial fibrillation
  • atrial flutter
  • chronic kidney disease
  • dronedarone
  • renal function
  • SINUS RHYTHM
  • MAINTENANCE
  • PREVENTION
  • MANAGEMENT
  • SOTALOL
  • DISEASE
  • GFR

Cite this